Delivery Order SPE2DB22D3004-SPE2DB24FPM08
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564043739 Ondansetron ODT 8 mg tablet 30s. The contract has a ceiling value of $11,071.04 and an ultimate completion date of March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a standalone delivery order and not associated with a larger contract vehicle. No set-aside...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,734.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 8 mg tablets. The contract has a completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,635,055 units of the pharmaceutical product Ondansetron ODT 4 MG Tablet 30S. The contract has a potential value of $5,262.72 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,755,841 units of the pharmaceutical product Ondansetron ODT 8 MG Tablet. The contract has a completion date of February 26, 2024, a potential value of $2,677.53, and was not subject to any set-aside requirements. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these pharmaceutical supplies from its...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 4 mg tablets in Conshohocken, Pennsylvania. The order has a potential value of $2,083.80 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,643,171 units of Ondansetron ODT 8 mg tablets in 30-count packages. The $2,239.95 contract has a completion date of February 14, 2024 and was awarded on February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is part of a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Ondansetron ODT 4 mg tablets. The order, valued at $3,672.70, has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 4 mg tablets. The contract has a potential value of $1,189.79 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and operates out of its Corporate Office division in Conshohocken, Pennsylvania. This delivery order is part of a larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,152,895 units of Ondansetron ODT 8 mg tablets in 30-count packages. The $8,832.72 order has a completion date of December 21, 2023 and was awarded on December 20, 2023. AmerisourceBergen Drug Corp, operating out of its corporate office in Conshohocken, Pennsylvania, is a prime contractor that regularly supplies...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,225 units of Ondansetron ODT 4 mg tablets. The $1,261.72 contract has a completion date of January 4, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceutical products and medical supplies to support DLA Troop Support Medical facilities and programs. This delivery order is...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPM08Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563790325 - Ondansetron ODT 8 mg Tablet 30s. The contract has a potential value of $2,603.40 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this delivery order. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 2/27/24 |